our wide range of products
Intermediates Product List
Sr. No | Products | Intermediate | CAS # |
---|---|---|---|
1 | Apixaban | Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 503614-91-3 |
2 | Apremilast | (S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamine N-acetyl-L-leucine salt | 608141-43-1 |
3 | Aprepitant | (2R,3S) -2-[(1R)-1-[3,5-Bis(trifluoromethyl) phenyl] ethoxy]-3-(4-fluorophenly)morpholine hydrochloride (APT07) | 171482-05-6 |
N-(2-chloro-1-methyl-ethylidene)-hydrazinecarboxylic acid methyl ester | 155742-64-6 | ||
4 | Azelnidipine | 1-Benzhydrylazetidin-3-yl 3-amino-3-iminopropanoate acetate | 170749-59-4 |
5 | Bazedoxifene | 3-Methyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-1H-indole | 198479-63-9 |
1-(2-(4-(Chloromethyl )phenoxy)ethyl)azepane hydrochloride | 223251-25-0 | ||
6 | Cariprazine HCl | N'-[trans-4-[2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N-dimethylurea | 839712-12-8 |
7 | Cinacalcet | 3-(3-Trifluoromethylphenyl)propanol | 78573-45-2 |
R-(+)-1-(1-Naphthyl)Ethylamine | 3886-70-2 | ||
8 | Clarithromycin | 2',4''-O-bis-(trimethylsilyl)-6-O-methylerythromycinA 9-[O-(1-methoxy-1-methylethyl)oxime] | 119699-81-9 |
Silylated Erythromycin Oxime Ketal | 119665-76-8 | ||
9 | Dabrafenib Mesylate | Methyl 3-(2,6-difluoro-benzenesulfonylamino)-2-fluoro-benzoate | 1195768-19-4 |
10 | Droperidol | 1-(1,2,3,6-Tetrahydro-pyridin-4-yl)-1,3-dihydro-benzoimidazol-2-one | 2147-83-3 |
11 | Edoxaban | N1-((1S,2R,4S)-2-Amino-4-(dimethylcarbamoyl)cyclohexyl)-N2-(5-chloropyridin- 2-yl)oxalamide | 480452-37-7 |
12 | Elexacaftor | 2-Chloro-6-[3-(3,3,3-trifluoro-2,2-dimethyl-propoxy)-pyrazol-1-yl]-nicotinic acid tert-butyl ester | 2229861-16-7 |
2-chloro-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)nicotinic acid | 2229861-17-8 | ||
2-chloro-N-((1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)nicotinamide | 2229861-18-9 | ||
13 | Linagliptin | 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione | 853029-57-9 |
N-[(3R)-1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-carbamic Acid 1,1-Dimethylethyl Ester | 668273-75-4 | ||
14 | Mirabegron | (R)-2-[2-(4-Amino-phenyl)-ethylamino]-1-phenyl-ethanol | 391901-45-4 |
2-[2-(4-Amino-phenyl)-ethylamino]-1-phenyl-ethanol Hydrochloride | 521284-22-0 | ||
15 | Niraparib Tosylate | 2-Methyl-2-propanyl (3S)-3-(4-bromophenyl)-1-piperidinecarboxylate | 1476776-55-2 |
Tert-butyl 3-[4-[7-(tert-butylcarbamoyl)-2H-indazol-2-yl]phenyl]piperidine-1-carboxylate | 1476776-97-2 | ||
16 | Pacritinib Citrate | 3-Allyloxymethyl-4-(2-pyrrolidin-1-yl-ethoxy)phenylamine | 937273-33-1 |
[4-(3-allyloxymethyl-phenyl)-pyrimidin-2-yl]-[3-allyloxymethyl-4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine | 937273-34-2 | ||
17 | Ponatinib Hydrochloride | 3-Iodo-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide | 943320-50-1 |
18 | Relugolix | 1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxy-3-pyridazinyl)-6-(4-nitrophenyl)-thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione,hydrochloride | 1589503-95-6 |
N-[(2,6-difluorophenyl)methyl]-N-[4-[(dimethylamino)methyl]-3-[[(6-methoxy-3-pyridazinyl)amino]carbonyl]-5-(4-nitrophenyl)-2-thienyl]-, ethyl ester | 1589503-94-5 | ||
1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxy-3-pyridazinyl)-6-(4-nitrophenyl)-thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione,hydrochloride | 1589503-99-0 | ||
1-(2,6-difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxy-3-pyridazinyl)-6-(4-aminophenyl)-thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione,hydrochloride | 1589503-93-4 | ||
19 | Ribociclib Succinate | 2-Chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide | 1211443-61-6 |
tert-butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | 1374639-78-7 | ||
20 | Rivaroxaban | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one hydrochloride | 898543-06-1 |
21 | Selumetinib Sulfate | Methyl 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylate | 606144-02-9 |
6-(4-Bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid | 606144-04-1 | ||
6-(4-Bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-vinyloxy-ethoxy)-amide | 606144-05-2 | ||
22 | Suvorexant | [(7R)-Hexahydro-7-methyl-4-(phenylmethyl)-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone; | 1620097-07-5 |
(R)-(7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone | 1030377-32-2 | ||
23 | Telotristat Ethyl | (R)-1-[4-Chloro-2-(3-methyl-pyrazol-1-yl)-phenyl]-2,2,2-trifluoro-ethanol | 1033805-26-3 |
2-(S)-Amino-3-[4-(2-amino-6-{R-1-[4-chloro-2-(3-methyl-pyrazol-1-yl)-phenyl]-2,2,2-trifluoro-ethoxy}-pyrimidin-4-yl)-phenyl]-propionic acid | 1033805-28-5 | ||
24 | Tofacitinib Citrate | N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 477600-74-1 |
25 | Trametinib Dimethyl Sulfoxide | 3-Cyclopropyl-1-(2-fluoro-4-iodophenyl)-5-hydroxy-6,8-dimethylpyrido[2,3-d]pyrimidine-2,4,7(1H,3H,8H)-trione | 871700-07-1 |
N-{4-[3-Cyclopropyl-1-(2-fluoro-4-iodo-phenyl)-6,8-dimethyl-2,4,7-trioxo-1,2,3,4,7,8-hexahydro-pyrido[2,3-d]pyrimidin-5-ylamino]-phenyl}-acetamide | 871700-25-3 | ||
26 | Vemurafenib | N-{3-[(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-oxo-methyl]-2,4-difluoro-phenyl}-propane-1-sulfonamide | 918504-27-5 |
27 | Vismodegib | 2-(2-Chloro-5-nitro-phenyl)-pyridine | 879088-40-1 |
4-Chloro-3-pyridin-2-yl-phenylamine | 879088-41-2 |
*All Intermediates are available with DMF in CTD format
*Intermediates of In-Patent API’s are not offered commercially in territories where such
patents are applicable
*Intermediates available for Strategic requirements Regulated Markets.
used by millions
Trusted By Pharmas Around the World.
Don’t just take our word for it! We already work with numerous pharmaceutical organisations who have trusted us with our wide range of products.
Phone
+91-22-40390400
+91 7039024932
Location
811, Summit Business Bay,Andheri Kurla rd, Andheri(E), Mumbai 400090 - India
info@mehtaapi.com
Office Hours
M-F: 9am - 6pm
S-S: 9am - 4pm
Subscribe for Updates